Search Results

search
Ampersand-logo-color-large.png
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements
March 19, 2025 07:00 ET | Ampersand Biomedicines
$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in immuno-inflammation and immuno-oncology planned to enter...
Curevo_Large.png
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
March 17, 2025 08:00 ET | Curevo Vaccine
Curevo Vaccine closes a $110 million Series B round led by Medicxi, with new investors OrbiMed, HBM Healthcare Investments, and Sanofi Ventures.
Qsic_Logo.jpg
Qsic Secures $25 Million USD in Series B Funding to Reinvent In-Store Audio For Retail Media
January 28, 2025 08:01 ET | Qsic
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, today announced that it closed a...
Angelini Ventures Logo clear background.png
Angelini Ventures co-leads €35 million oversubscribed Series B financing in Nobi, an AgeTech company, to expand AI-enabled technology across senior care facilities globally
January 28, 2025 01:05 ET | Angelini Ventures
Angelini Ventures’ investment in Nobi demonstrates its continued strategic focus on digital health and connected health devices and represents a significant opportunity to improve the wellbeing of...
labviva-logo-dark.png
Labviva Secures $25M to Accelerate Product Development and Global Expansion
January 13, 2025 06:25 ET | Labviva
Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B.
Citryll logo.png
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
December 09, 2024 02:00 ET | Citryll
CITRYLL RAISES EUR 85 MILLION SERIES B TO ADVANCE NOVEL NET-TARGETING THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and...
Team Photo
11x Raises a $50 Million Series B Led by Andreessen Horowitz to Accelerate the Era of Digital Workers
November 11, 2024 12:00 ET | 11X AI INC.
SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by...
Synox Logo.jpg
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
October 30, 2024 07:00 ET | SynOx Therapeutics Limited
Gilde Healthcare Leads Series B Extension, Joining Premier Syndicate of Leading Life Science Investors Funding Supports Registrational Phase 3 TANGENT Trial of Emactuzumab, a Best-in-Class CSF-1...
Fable_logo.png
Fable Raises $25m in Series B Funding to Protect Digital Accessibility in the Age of AI
October 16, 2024 09:01 ET | Fable
Fable Raises $25m in Series B Funding to Protect Accessibility in the Age of AI
purespring logo.png
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 09, 2024 07:00 ET | Purespring Therapeutics
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...